Related Experiment Video

Updated: Aug 19, 2026

A Rabbit Aortic Valve Stenosis Model Induced by Direct Balloon Injury
07:10

A Rabbit Aortic Valve Stenosis Model Induced by Direct Balloon Injury

Published on: March 31, 2023

Aortic valve papillary fibroelastoma

Wlodzimierz Kuroczynski1, Ulrich Hake, Diethard Pruefer

  • 1Department of Cardiothoracic and Vascular Surgery, Johannes Gutenberg-University, Mainz, Germany. kuroczynski@uni-mainz.de

The Journal of Heart Valve Disease
|February 11, 2005
PubMed

Insights

Cardiac papillary fibroelastoma (CPF), a rare benign heart tumor, is increasingly diagnosed with echocardiography. Surgical removal is effective for CPF, preventing potential cardiac or cerebrovascular ischemia.

Area of Science:

  • Cardiology
  • Oncology

Background:

  • Cardiac papillary fibroelastoma (CPF) is a rare, benign primary cardiac tumor.
  • It is the third most common primary cardiac tumor and the most frequent tumor of the valvular endothelium.
  • Historically diagnosed post-mortem or incidentally during surgery, CPF is now detectable in living patients.

Observation:

  • Transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) enable in vivo diagnosis of CPF.
  • CPF can lead to cerebrovascular or cardiac ischemia through embolization or vascular ostia occlusion.
  • Emboli may originate from tumor fragments or associated thrombus.

Findings:

  • The study reports a case of aortic valve CPF diagnosed via TEE.
  • Surgical excision of the aortic valve CPF was successfully performed.

Implications:

  • Early diagnosis of CPF using advanced echocardiography is crucial.
  • Surgical intervention for CPF can prevent serious embolic complications.
  • This case highlights the importance of TEE in diagnosing and managing CPF.

More Related Videos

An Ex Vivo Porcine Model for Hydrodynamic Testing of Experimental Aortic Valve Procedures and Novel Medical Devices06:56

An Ex Vivo Porcine Model for Hydrodynamic Testing of Experimental Aortic Valve Procedures and Novel Medical Devices

Published on: August 25, 2023

Isolation of Human Primary Valve Cells for In vitro Disease Modeling07:31

Isolation of Human Primary Valve Cells for In vitro Disease Modeling

Published on: April 16, 2021

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...